Cargando…
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
PURPOSE OF REVIEW: COVID-19 is highly contagious; since it was first identified, the virus has rapidly spread to more than 100 countries and was declared a pandemic on March 11, 2020, by the World Health Organization (WHO). This disease presents several challenges when managing patients with leukemi...
Autores principales: | Delgado, Nancy, Torres, Anahí |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881701/ https://www.ncbi.nlm.nih.gov/pubmed/35218499 http://dx.doi.org/10.1007/s11912-021-01169-w |
Ejemplares similares
-
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
por: Marando, Ludovica, et al.
Publicado: (2020) -
Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021) -
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
por: Meillon-Garcia, Luis Antonio, et al.
Publicado: (2020) -
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission
por: Stuckey, Ruth, et al.
Publicado: (2022) -
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)